MGEN insider filings

Viridian Therapeutics, Inc.\DE — 12 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-01-19. Screen MGEN transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for MGEN between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Viridian Therapeutics, Inc.\DE

FiledFormInsiderReported transactionsSource
2021-01-194Escolar Diana — Former Chief Medical OfficerHoldings only — no transactions reportedEDGAR
2021-01-194Rauch Lee M.Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-01-154Marshall William StuartHoldings only — no transactions reportedEDGAR
2020-11-164Logos Global Master Fund LP — 10% ownerPurchase (P): 250,000 @ $1.10 · Purchase (P): 100,000 @ $1.16 · Purchase (P): 126,667 @ $14.84EDGAR
2020-10-304Violin Jonathan — President and COOOther (J): 50,124 · Other (J): 4,338,079 (derivative) · Other (J): 9,413 (derivative)EDGAR
2020-10-304Fairmount Funds Management LLC — Director
Fairmount Healthcare Fund GP LLC — Director
Fairmount Healthcare Fund II GP LLC — Director
Fairmount Healthcare Fund L.P. — Director
Fairmount Healthcare Fund II L.P. — Director
Purchase (P): 5,494 (derivative) @ $465.96 · Purchase (P): 28,843 (derivative) @ $465.96EDGAR
2020-10-294Harwin Peter Evan — DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
2020-10-294Kiselak Tomas — DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
2020-10-294Fairmount Funds Management LLC — Director
Fairmount Healthcare Fund GP LLC — Director
Fairmount Healthcare Fund II GP LLC — Director
Fairmount Healthcare Fund L.P. — Director
Fairmount Healthcare Fund II L.P. — Director
Other (J): 87,891 · Other (J): 438,502 · Other (J): 16,505 (derivative) · Other (J): 82,349 (derivative)EDGAR
2020-09-174/ARauch Lee M. — President & CEO, DirectorGrant/award (A): 900,000 (derivative) @ $0EDGAR
2020-09-154Rauch Lee M. — President & CEO, DirectorGrant/award (A): 900,000 (derivative) @ $0EDGAR
2020-08-254Marshall William Stuart — President & CEO, DirectorHoldings only — no transactions reportedEDGAR

Recent 8-K events — Viridian Therapeutics, Inc.\DE

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-098-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-298-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-038-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-288-K1.02 — Termination of a Material Definitive AgreementEDGAR
2026-05-268-K1.01 — Entry into a Material Definitive AgreementEDGAR
2026-05-118-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-058-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=MGEN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs